Advertisement

Neurologische Komplikationen der Vaskulitiden

Chapter

Zusammenfassung

Vaskulitiden sind entzündliche Erkrankungen der Blutgefäße, die in primäre und sekundäre Formen unterteilt werden. Sekundäre Vaskulitiden treten im Rahmen anderer Grunderkrankungen auf, z. B. bei Kollagenosen oder rheumatoider Arthritis. Auch können sekundäre Vaskulitiden durch Medikamente, Infektionen oder Neoplasien verursacht werden. In diesem Kapitel werden nur die primären Vaskulitiden besprochen. Eine Einteilung der Vaskulitiden erfolgt unter anderem basierend auf histologischen Veränderungen, anhand immunologischer Marker sowie des Gefäßkalibers. Die primären Vaskulitiden werden nach der Chapel-Hill-Klassifikation eingeteilt, die zuletzt 2012 revidiert wurde.

Literatur

  1. Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122:2171–2182CrossRefGoogle Scholar
  2. Alexander MD, Yuan C, Rutman A, Tirschwell DL, Palagallo G, Gandhi D, Sekhar LN, Mossa-Basha M (2016) High-resolution intracranial vessel wall imaging: imaging beyond the lumen. J Neurol Neurosurg Psychiatry 87(6):589–597CrossRefGoogle Scholar
  3. Alrawi A, Trobe JD, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53(4):858–860CrossRefGoogle Scholar
  4. Alreshaid AA, Powers WJ (2003) Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology 61(6):831–833CrossRefGoogle Scholar
  5. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefGoogle Scholar
  6. Berlit P (2004) Cerebral vasculitis. Nervenarzt 75(8):817–828CrossRefGoogle Scholar
  7. Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66:704–709CrossRefGoogle Scholar
  8. Bley TA, Reinhard M, Hauenstein C, Markl M, Warnatz K, Hetzel A, Uhl M, Vaith P, Langer M (2008) Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 58:2574–2578CrossRefGoogle Scholar
  9. Boyev LR, Miller NR, Green WR (1999) Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 128:211–215CrossRefGoogle Scholar
  10. Calabrese LH (1997) Therapy of systemic vasculitis. Neurol Clin 15(4):973–991CrossRefGoogle Scholar
  11. Calabrese LH, Mallek JA (1997) Primary angiitis of the central nervous system. Report of 8 cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 76:20–39Google Scholar
  12. Dasgupta B et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism/American college of rheumatology collaborative initiaitve. Ann Rheum Dis 71:484–492CrossRefGoogle Scholar
  13. Dejaco C et al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799–1807CrossRefGoogle Scholar
  14. Demaerel P, De Ruyter N, Maes F, Velghe B, Wilms G (2004) Magnetic resonance angiography in suspected cerebral vasculitis. Eur Radiol 14(6):1005–1012CrossRefGoogle Scholar
  15. Ducros A (2012) Reversible cerebral vasoconstriktion syndrome. Lancet Neurol 11(10):906–917CrossRefGoogle Scholar
  16. Falk RJ, Hogan S, Carey TS, Jennette JC (1990) Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113:656–663CrossRefGoogle Scholar
  17. Gayraud M, Guillevin L, Toumelin P le, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44:666–675CrossRefGoogle Scholar
  18. Guillevin L, Lhote F, Sauvaget F et al (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53:334–337CrossRefGoogle Scholar
  19. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28CrossRefGoogle Scholar
  20. Guillevin L, Lhote F, Gherardi R (1997) Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 15:865–886CrossRefGoogle Scholar
  21. Hajj-Ali RA, Calabrese LH (2009) Central nervous system vasculitis. Curr Opin Rheumatol 21(1):10–18CrossRefGoogle Scholar
  22. Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E (2011) Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257–266CrossRefGoogle Scholar
  23. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefGoogle Scholar
  24. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s Disease. Lancet 335:1078–1080Google Scholar
  25. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11CrossRefGoogle Scholar
  26. Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2183–2194CrossRefGoogle Scholar
  27. Kuker W (2007) Imaging of cerebral vasculitis. Int J Stroke 2(3):184–190CrossRefGoogle Scholar
  28. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefGoogle Scholar
  29. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093CrossRefGoogle Scholar
  30. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American college of rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100CrossRefGoogle Scholar
  31. Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C (2009) Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 33:35–43CrossRefGoogle Scholar
  32. Néel A, Pagnoux C (2009) Primary angiitis of the central nervous system. Clin Exp Rheumatol 27(1 Suppl 52):S95–107PubMedGoogle Scholar
  33. Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34:284–292CrossRefGoogle Scholar
  34. Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 38:1208–12CrossRefGoogle Scholar
  35. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99CrossRefGoogle Scholar
  36. Salvarani C, Brown RD Jr, Christianson T, Miller DV, Giannini C, Huston J 3rd, Hunder GG (2015) An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis. Description of 163 patients. Medicine 94(21):e738CrossRefGoogle Scholar
  37. Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336–1342CrossRefGoogle Scholar
  38. Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A (2008) Prognosis of large-vessel giant cell arteritis. Rheumatology 47:1406–1408CrossRefGoogle Scholar
  39. Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine 85:54–65CrossRefGoogle Scholar
  40. Siva A (2001) Vasculitis of the nervous system. J Neurol 248(6):451–468CrossRefGoogle Scholar
  41. Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098CrossRefGoogle Scholar
  42. Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB (1994) Sensitivities of noninvasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol 21(7):1277–1282PubMedGoogle Scholar
  43. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232CrossRefGoogle Scholar
  44. Torres J, Loomis C, Cucchiara B, Smith M, Messé S (2016) Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis. Stroke 47(8):2127–2129CrossRefGoogle Scholar
  45. Vital A, Vital C (2006) Neuromuscular biopsy and diagnosis of vasculitis. Ann Pathol 26:247–255CrossRefGoogle Scholar
  46. Weyland CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50–57CrossRefGoogle Scholar
  47. Wipfler-Freissmuth E, Moosig F, Schirmer M (2009) Recommendations of the European League Against Rheumatism (EULAR) for the treatment of „large-vessel vasculitides“. Z Rheumatol 68:260–263CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.HannoverDeutschland
  2. 2.BarsinghausenDeutschland

Personalised recommendations